Phase II study of biweekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer.
Kunisaki C, Takahashi M, Makino H, Oshima T, Fujii S, Takagawa R, Kimura J, Kosaka T, Ono HA, Akiyama H, Kameda K, Kito F, Morita S, Endo I.
Kunisaki C, et al. Among authors: ono ha.
Cancer Chemother Pharmacol. 2011 Jun;67(6):1363-8. doi: 10.1007/s00280-010-1433-7. Epub 2010 Aug 28.
Cancer Chemother Pharmacol. 2011.
PMID: 20803016
Clinical Trial.